South San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, Walking Fish Therapeutics is raising $23,399,996.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Rusty Williams played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Walking Fish Therapeutics
Walking Fish has created a broad B cell platform for oncology, regenerative medicine, autoimmune disease, and recombinant antibody production. As a leader in B cell engineering, Walking Fish has made critical advances in engineering technologies and has a deep understanding about B cell biology. The WFT team includes experienced researchers excited about our new approach to the treatment of severe diseases.

To learn more about Walking Fish Therapeutics, visit http://www.walkingfishtx.com/

Contact:
Rusty Williams, Chief Executive Officer
650-331-0242
https://www.linkedin.com/in/rusty-williams-a136a5104/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved